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INTRODUCTION
In cancer, the morphological assessment of histological tissue
samples is a fundamental part of both diagnosis and prognosis (Beck
et al., 2011). Histopathological grading is subjective (Wöhlke et al.,
2011) and there exists substantial variability among individual
pathologists (Fanshawe et al., 2008). Moreover, particular
morphological phenomena such as tumour budding, characterised
by relatively small clusters of tumour cells becoming detached from
the main tumour body, are known to be indicators of prognosis
but are difficult to describe quantifiably and objectively (Wang et
al., 2009). Morphometric image analysis has the potential to aid
standardisation of interpretation of histopathology samples,
extending to the postsurgical development of carcinomas (Eynard
et al., 2009). Moreover, advances in laboratory methods provide
quantitative, objective data platforms upon which morphometric
image analysis can be founded (Wöhlke et al., 2011). Morphometric
image analysis can be undertaken at a range of scales including
(combinations of) subcellular, cellular and tissue scale (Eynard et
al., 2009) and with a diversity of quantitative computational tools
(Yaffe, 2008). For example, Beck and co-workers describe a software
tool that can integrate an impressive range of quantitative
morphometrics of breast cancer epithelium and the stroma (Beck
et al., 2011). Their analysis considered a range of data scales: fine-
scale analyses include nuclei size and shape; higher level analyses
explore sample structure, including relation measures such as mean
distance between typical and atypical nuclei in stroma and epithelial
tissues. They demonstrated that a set of multiscale features in
cancer stroma are significantly associated with survival. Other work
has characterised tissue structure itself, including measures of area
and texture. Given the link between risk of development of breast
cancer and breast tissue density (Boehm et al., 2008), area measures
of different tissue densities are of prognostic value in some but not
all case studies (Yaffe, 2008).
Textural measures characterise the morphological features of
tissue, in particular the distribution of parenchymal and stromal
tissue (Boehm et al., 2008). A common approach is to characterise
tissue by its fractal dimension, which provides a measure of self-
similarity and, thus, irregularity in an object (Franzén et al., 2008).
Fractal geometry has been applied to a range of different cancers
and in conjunction with other measures (Goutzanis et al., 2009).
For example, it was explored whether the fractal dimension of
nuclear chromatin might be used as a predictor of survival in
melanoma patients (Bedin et al., 2010). The invasive front of colon
carcinomas was quantified in terms of a complexity index based
on fractal dimension complemented by the number of tumour cell
clusters (Franzén et al., 2008). This complexity index was tested
against independent pathology classification and performed better
than fractal dimension alone.
Another metric set used in texture analysis is Minkowski
functionals, a family of statistical metrics able to characterise n-
dimensional space geometrically and topologically (Arns et al.,
2010). Two-dimensional (2D) images can be described by three
Minkowski functionals: area fraction, boundary length and the
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SUMMARY
In cancer, morphological assessment of histological tissue samples is a fundamental part of both diagnosis and prognosis. Image analysis offers
opportunities to support that assessment through quantitative metrics of morphology. Generally, morphometric analysis is carried out on two-
dimensional tissue section data and so only represents a small fraction of any tumour. We present a novel application of three-dimensional (3D)
morphometrics for 3D imaging data obtained from tumours grown in a culture model. Minkowski functionals, a set of measures that characterise
geometry and topology in n-dimensional space, are used to quantify tumour topology in the absence of and in response to therapeutic intervention.
These measures are used to stratify the morphological response of tumours to therapeutic intervention. Breast tumours are characterised by estrogen
receptor (ER) status, human epidermal growth factor receptor (HER)2 status and tumour grade. Previously, we have shown that ER status is associated
with tumour volume in response to tamoxifen treatment ex vivo. Here, HER2 status is found to predict the changes in morphology other than volume
as a result of tamoxifen treatment ex vivo. Finally, we show the extent to which Minkowski functionals might be used to predict tumour grade.
Minkowski functionals are generalisable to any 3D data set, including in vivo and cellular systems. This quantitative topological analysis can provide
a valuable link among biomarkers, drug intervention and tumour morphology that is complementary to existing, non-morphological measures of
tumour response to intervention and could ultimately inform patient treatment.
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Euler number (Mattfeldt et al., 2007), and these have been used to
characterise tissue samples and have been linked to pathology
classification using 2D images of breast tissue. Minkowski
functionals were used for images segmented into phases of stroma,
epithelium and luminal space. In this instance, data area fraction
of the epithelium phase was a strong indicator of the presence of
a mammary carcinoma. Minkowski functionals have also been used
to classify 2D X-ray attenuation patterns of breast tissue (Boehm
et al., 2008). Against independent clinical classification, Minkowski
functionals were able to classify tissue into three categories (fibrotic,
atrophic and normal) far better than chance.
Most morphological studies, including those noted above,
consider 2D tissue sections. Volume measures in three dimensions
(3D) are likely to be of even greater prognostic value (Yaffe, 2008).
A recent study has linked morphometric data from 3D culture-
based tumours to gene expression data (Han et al., 2010).
Morphometric analysis was undertaken on a large number of 2D
images of those tumours, and this morphological profile was
linked to gene expression data in two ways: first, clusters of
morphologically similar cell lines were determined and genes that
discriminated among clusters identified; and, second, genes that
were able to discriminate among separate morphological features
were identified. The first analysis determined broad associations
between phenotype and genotype and the second analysis linked
particular features of specific cell lines to gene expression,
suggesting mechanisms linking phenotype and genotype.
We reported previously on a 3D culture model, which enables
the spread of human breast cancer ex vivo, within stromal type I
collagen. Volumetric analysis of breast cancers in this system
showed that response to drugs such as tamoxifen mimics responses
seen in the clinic (Leeper et al., 2012). Specifically, we observed a
significant effect of tamoxifen treatment on tumour volume for
estrogen receptor-positive (ER+), but not estrogen receptor-
negative (ER–) tumours. Here, we describe investigation into the
impact of tamoxifen on morphological characteristics other than
volume. To do this, we characterised tumours grown in 3D cultures
using Minkowski functionals. We show how these topological
characteristics might be used to stratify morphological response
of tumours to therapeutic intervention in a complementary manner
to the existing range of tumour-response biomarkers. We make the
novel observation that human epidermal growth factor receptor
(HER)2 status can predict the changes in morphology resulting
from tamoxifen treatment ex vivo. Finally, we show the extent to
which Minkowski functionals can be used to predict tumour
grade.
RESULTS
Preliminary analysis
Three-dimensional images can be described by four Minkowski
functionals that relate to volume, surface area, integral mean
curvature (IMC) and integral total curvature (ITC) (see Materials
and Methods for further details). The volume and surface area of
the tumour are readily understood. IMC and ITC are measures of
curvedness and connectedness, respectively, and both are signed
quantities. IMC is a numerical summation of the average curvature
at each point on the detected surface of the tumour. A locally convex
surface makes a positive contribution and locally concave surfaces
make a negative contribution. Smooth surfaces are expected to have
lower magnitude IMC values relative to more rugged surfaces. The
topological measure ITC describes the connectedness of tumour
fragments detected within an image; large values of ITC are
indicative of complex tumours such as those with invading fingers.
Fig. 1 shows reconstructed optical projection tomography (OPT)
images for three illustrative tumours. Fig. 1A shows a tumour with
low IMC and high ITC, with a smooth spheroidal main body and
significant protrusions on one side. Fig. 1B shows a tumour with
high IMC and high ITC, with a combination of an aspherical
tumour body and several protrusions. Fig. 1C shows a tumour with
high IMC and low ITC; the tumour is rugged on its surface with
no substantial protrusions.
Using Minkowski functionals, we determined associations
between tamoxifen treatment status and either ER status or HER2
status for all tumours. In addition to ER and HER2 status of each
of the 30 tumour explant preparations and information on whether
or not a tumour had been treated by tamoxifen, supplementary
material Table S1 provides the results of analysis, with absolute
values for all functional measures. Also included are two
measurements of tumour aggressiveness: lymph node status and
tumour grade.
TRANSLATIONAL IMPACT
Clinical issue
Carcinomas make up at least 80% of human solid tumours. As the cancer
progresses, the transformed epithelia spread locally into the connective tissue
(stroma), ultimately forming local and distal metastases. The spread of cancer
thus occurs in three-dimensional (3D) space. This has been modelled in vitro
using extracellular matrix-based tissue culture models. In breast research,
compliant collagen type I or basement-membrane extract have been used
successfully to model both normal development and cell transformation.
Nevertheless, the analysis of 3D cultures is almost exclusively undertaken
using only 2D techniques, which are frequently based on microscopic analysis
of formalin-fixed sample sections. Thus, there is a lack of knowledge regarding
the 3D morphological properties of human cancer as it occurs naturally and of
3D culture-based cancer models. Quantitative morphometrics of cancer spread
would allow direct comparisons of tumour grade and biomarkers.
Furthermore, they would enable measurements of drug responses in a 3D
context.
Results
This paper shows that Minkowski functionals – a set of statistical metrics that
characterise geometry and topology in n-dimensional space – can be used to
quantify tumour topology in the absence of and in response to therapeutic
intervention. The authors applied these measures to investigate human breast
cancer ex vivo spread. First, they report that Minkowski functionals are closely
correlated with clinically determined tumour grade. Second, they find that
estrogen-negative (ER–) breast tumours exposed to tamoxifen ex vivo undergo
morphological changes that cannot be observed using volumetric
measurements alone. Third, HER2 status in estrogen-positive (ER+) tumours
seems to predict their responsiveness to tamoxifen as determined by
Minkowski functionals.
Implications and future directions
Tumours are a 3D entity, and their direct and indirect effects, including
invasion and metastasis, depend on their 3D characteristics. This paper
presents a quantitative method for analysing cancer spread and response to
therapy in 3D models. This method is broadly applicable to the study of
various cancer types and established 3D tumour models. Being able to
quantify aspects of 3D growth, and to measure the effects of therapy and
environment, opens up new avenues for biomarker exploration.
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In order that volume effects did not dominate morphological
analysis, we normalised all surface area, IMC and ITC values by
volume. For surface area and IMC this provides us with measures
of surface area per unit volume (SA/V; density of tumour surface
per tumour volume) and curvature per unit volume (IMC/V; density
of tumour surface curvature per tumour volume), respectively.
Tumours with lower SA/V values are more spherical; tumours with
lower IMC/V values are less rugged overall. Moreover, the
normalisation of IMC and surface area was supported by the strong
correlation between both of these functionals and volume (P<0.01).
This correlation is intuitively reasonable in that, for a fixed
resolution, larger volume tumours will have a greater surface area
and IMC than morphologically similar but smaller tumours. The
normalisation was also applied to ITC for reasons of consistency
across Minkowski functionals, though not clearly indicated by a
significant correlation with volume.
Fig. 2 shows IMC/V, ITC/V and SA/V values for treated and
untreated tumours, with both IMC/V and ITC/V plotted against
SA/V. Fig. 2A,C depict tumours without tamoxifen treatment; Fig.
2B,D depict tumours with tamoxifen treatment. The effect of
tamoxifen on Minkowski functional values is clearly shown.
Generally, treated tumours have lower values of SA/V and IMC/V
(Fig. 2, compare A with B) and ITC/V (Fig. 2, compare C with D)
than untreated tumours and, therefore, tamoxifen application
results in tumours that are rounder, smoother and less fingered.
In our plots of Minkowski functionals for tumours with and
without treatment we also highlight the tumour subtype: ER and
HER2 status tumours in Figs 2 and 3, respectively. Note that the
tumours in Fig. 3 are identical in their Minkowski functional values
to those in Fig. 2 and so the points overlap. The difference between
the two figures lies in the patterning of ER and HER2 status across
the treated and untreated tumours. In Fig. 2A-D there is no clear
distinction between patterns for ER+ and ER– in either treated or
untreated tumour sets. Likewise, Fig. 3A,C (untreated tumours)
shows no clear distinction between HER2+ and HER2– status
tumours. Notably, we observed a clear separation based on HER2
Fig. 1. Illustrative 2D sections of OPT scan source data for three tumours. (A)ER–, HER2– tumour treated with tamoxifen with low (smooth) IMC and high
Euler characteristic (protrusions), ITC; (B) Untreated ER+, HER2+ tumour with high IMC (rugged) and high ITC; (C) ER–, HER2+ tumour treated with tamoxifen with
a low ITC (no protrusions) and high IMC (rugged). Note that Minkowski functionals are calculated on the basis of segmented image files and normalised by
volume. Image contrast in the original OPT scan data has been enhanced for photographic reproduction purposes (but not for analysis).
Fig. 2. Plots of Minkowski functionals IMC, ITC and
surface area normalised by volume. (A,C)IMC/V and
ITC/V, respectively, plotted against SA/V for untreated
tumours. (B,D)IMC/V and ITC/V respectively plotted
against SA/V for tamoxifen-treated tumours. ER status
confers no clear discrimination in morphological
response to tamoxifen. Open circles, ER–; closed circles,
ER+.
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status for treated tumours (Fig. 3B,D), with HER2– tumours being
more responsive in terms of morphological change to tamoxifen
treatment than HER2+ tumours for IMC/V and SA/V but not
ITC/V.
From this preliminary analysis, we hypothesised that that HER2
status provides better stratification of morphological response to
tamoxifen treatment than ER status.
Characterising the influence of tamoxifen and tumour subtype on
morphology
We sought to determine the influence of four categorical
explanatory variables (tamoxifen treatment, ER status, HER2 status
and node status) on the set of quantitative morphological response
variables (IMC/V, ITC/V and SA/V). Because we considered the
influence of four explanatory variables on three measures of
morphology, individual pair-wise comparisons could not take into
account other, possibly confounding, variables. An added
complication was that we did not have equal numbers of tumours
in each category (see supplementary material Table S1). Data of
this type can be analysed by factorial analysis of variance by
regression, where all explanatory variables are factors. Like multiple
linear regression, this analysis makes use of the general linear model
where the response variable (IMC/V, ITC/V and SA/V) is modelled
and the contributions of each factor and the interactions between
factors in the model assessed.
We first considered the effect of tamoxifen treatment, ER status,
HER2 status and node status on the morphological descriptors
IMC/V, ITC/V and SA/V for all tumours. Table 1 shows the
contributions of these explanatory variables on the Minkowski
functionals responses. The addition of tamoxifen into the model
is significant for SA/V, has a strong but not significant effect
(P0.07) for IMC/V and has no significant effect for ITC/V. The
addition of HER2 into the model had a significant effect for IMC/V
and SA/V but not for ITC/V. We also observed a significant effect
from the introduction of an interaction between ER and node status.
The inclusion of all other explanatory variables and interactions
had no significant effect on the model.
We next considered the influence of tumour subtype (ER± and
HER2± status) on tamoxifen response, together with the effects of
HER2 status on ER± tumour response and ER status on HER2±
tumour response. For ER-based tumour analysis, we also included
node status because of the observed interaction between ER and
node status shown in Table 1.
Table 2 shows the contributions of tamoxifen treatment and
HER2 status for tumours that are ER+ and for tumours that are
ER–. For ER+ tumours, the addition of tamoxifen to the model was
significant for SA/V but not for IMC/V or ITC/V. For ER– tumours,
the addition of tamoxifen to the model was significant for IMC/V
and SA/V but not for ITC/V. The addition of node status into the
model was significant for SA/V and ITC/V. All other factors for all
response variables were not significant.
We compared treated and untreated tumours for both ER+ and
ER– tumours using a t-test assuming unequal sample size and equal
variance. Specifically, treated ER+ tumours had a significantly lower
SA/V value than untreated tumours [all values expressed as mean
± s.d.; treated SA/V 208.55±19.95, untreated SA/V 244.92±38.70;
t(15)2.13, P0.05]. Treated ER– tumours had a significantly
smaller IMC/V value than untreated tumours [treated IMC/V
−8,424.49±2,215.07; untreated IMC/V −13,109.15±4,661.70;
t(11)2.2, P0.05]. Note that, for ER– tumours SA/V was lower in
treated tumours than in untreated tumours and this was nearly
significant (P0.07). There were no other significant differences in
morphological characteristics for ER+ or ER– tumours.
Table 3 shows the contributions of tamoxifen treatment and ER
status for tumours that are HER2+ and for tumours that are HER2–.
For HER2+ tumours, there were no significant factors for any
response variable. For HER2– tumours, the addition of tamoxifen
to the model was significant for IMC/V and SA/V but not for ITC/V,
and all other factors for all response variables were not significant.
When comparing treated and untreated HER2– tumours, the
Fig. 3. Plots of Minkowski functionals IMC, ITC and
surface area normalised by volume. (A,C)IMC/V and
ITC/V, respectively, plotted against SA/V for untreated
tumours. (B,D)IMC/V and ITC/V, respectively, plotted
against SA/V for tamoxifen-treated tumours. HER2
status offers a clear separation between tumours,
especially in B. Open circles, HER2–; closed circles,
HER2+.
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IMC/V value was significantly smaller for treated tumours than for
untreated tumours [treated IMC/V −7451.83±1406.29; untreated
IMC/V −11394.87±4243.42; t(20)2.09, P0.02]. Likewise, SA/V
was significantly lower for treated tumours compared with
untreated tumours [treated 193.91±15.01; untreated 245.28±42.67;
t(20)3.26, P<0.01]. There were no other significant differences in
morphological characteristics for HER2+ or HER2– tumours.
In addition to biological status, we also quantified changes in
proliferative and apoptotic activity in tumour materials, by staining
for Ki67 and cleaved caspase-3, respectively, for a subset (n6) of
tumours with available data (Leeper et al., 2012). We assessed the
correlation between both Ki67 and cleaved caspase-3 levels and
the Minkowski functionals in both treated and untreated tumours.
In treated tumours, we observed a near-significant and moderately
strong negative correlation between Ki67 levels and IMC/V
(R–0.79; P0.06 Spearman rank, n6) and the same strong
negative correlation for caspase-3 expression (not significant)
(R0.62, P0.18 Spearman rank, n6). All other correlations were
not significant.
Linking Minkowski functionals to tumour grade
Finally, we investigated the extent to which the Minkowski
functionals (normalised by volume) could be used to predict
tumour grade. Clinically, tumours are graded by pathologists,
independently of expected treatment, ER status or HER2 status.
Discriminant factor analysis, a well-known modelling approach for
prediction of a dependent categorical value from independent
variables (Boehm et al., 2008), was performed to predict tumour
grade (1, 2 or 3) using IMC/V, SA/V and ITC/V as independent
variables. The resulting classification table (Table 4) indicates that
the Minkowski functionals provided excellent predictive power for
three out of four categories. Grading was based on the tumours
observed in the patient and not the tumours in the collagen
environment (which were grown from sub-samples of the patient
tumour). Morphological characteristics relate to those sub-samples
grown in the collagen environment, and we assume that some of
morphological characteristics that attracted the grade classification
(1, 2 or 3) in vivo persist in the ex vivo experimental culture system.
Our analysis suggests that the morphology of tumours of grade
1 and 2 was not significantly impacted by tamoxifen treatment,
although we recognise the small numbers involved. By contrast,
tamoxifen had a significant impact on the morphology of grade 3
tumours. Almost all grade 3 tumours that were untreated are
classified as grade 3 morphologically. The near-perfect prediction
of in vivo grade from in vitro morphology, in spite of limited data,
supports our assumption that morphological characteristics persist
across sampling and systems. Moreover, we note that the majority
(75%) of clinically defined grade 3 tumours, treated with tamoxifen
ex vivo, are classified as grade 1 in the culture system. We propose
that this significant change in morphology is a consequence of drug
action: specifically, that tumours originally re-classified as grade 3
are classified as grade 1 as a result of tamoxifen treatment.
To further explore the relation between grading and Minkowski
functionals, we extended our analyses to consider the individual
measures used to determine grade. We used the AMN grading
system (Elston and Ellis, 1991) in which tumour grade is assessed
in terms of acinar or tubule formation, nuclear pleomorphism and
mitotic activity, with each element being scored a value of 1 (similar
to normal tissue) to 3 (does not resemble normal tissue). Nuclear
evaluation and mitotic count is assessed in the worst areas of the
sample whereas acinar or tubule formation is evaluated over the
whole tumour.
Results of the discriminant factor analysis are shown in Table 5.
In untreated tumours, we observed good agreement between the
pathological grade and the grade predicted by Minkowski
functionals for mitotic count, nuclear pleomorphism and acinar or
tubule formation for all tumour grades observed. In treated
tumours, we observed good agreement between the pathological
grade and that predicted by the Minkowski functionals for mitotic
count and nuclear pleomorphism for all tumour grades observed.
However, for treated tumours graded according to acinar or tubule
formation, only the Minkowski functionals prediction for grade 1
tumours agreed with the pathologist score. For grade 2 and 3
tumours, the Minkowski functionals predicted a grade score that
underestimated the grade of tumour (as grade 1). We propose that
this specific mis-categorisation reflects the change in tumour-scale
Table 1. Change in the explanatory power of the regression model 
for each variable 
Explanatory variables 
Response variables 
IMC/V SA/V ITC/V 
Tamoxifen 0.07 <0.01 0.313 
ER 0.05 0.05 0.82 
HER2 0.05 0.05 0.81 
Nodes 0.56 0.12 0.65 
Tamoxifen.ER 0.22 0.39 0.68 
Tamoxifen.HER2 0.67 0.43 0.96 
HER2.ER 0.42 0.83 0.46 
Tamoxifen.Nodes 0.64 0.83 0.79 
ER.Nodes 0.51 0.02 0.13 
P-values for the F-test on the change in the explanatory power of the regression model 
for each variable (tamoxifen treatment, ER, HER2 and lymph node status) and 
combination of variables introduced with respect to models for response variables 
(IMC/V, SA/V and ITC/V). Significant effects are highlighted in bold. 
Table 2. Change in the explanatory power of the regression model 
for each variable for ER+ and ER– tumours 
Explanatory variables 
Response variables 
IMC/V SA/V ITC/V 
ER+ tumours 
Tamoxifen 0.515 0.05 0.727 
HER2 0.10 0.33 0.56 
Nodes 0.63 0.61 0.38 
Tamoxifen.HER2 0.55 0.26 0.87 
ER– tumours 
Tamoxifen 0.05 0.03 0.09 
HER2 0.21 0.05 0.40 
Nodes 0.26 0.03 0.05 
Tamoxifen.HER2 0.77 0.90 0.99 
P-values for the F-test on the change in the explanatory power of the regression model 
for each variable (tamoxifen treatment, HER2 and lymph node status) and combination 
of variables introduced with respect to models for response variables (IMC/V, SA/V and 
ITC/V). Results are for ER+ and ER– tumours. Significant effects are highlighted in bold. 
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morphology as characterised by acinar or tubule formation induced
by tamoxifen application post-grading.
DISCUSSION
Carcinomas comprise at least 80% of human solid tumours. As the
cancer progresses, the transformed epithelia spread locally into the
connective tissue (stroma), ultimately forming local and distal
metastases (Valastyan and Weinberg, 2011). The spread of cancer
thus occurs in 3D space. This has been modelled in vitro using
extracellular matrix-based tissue culture models. In breast research,
compliant collagen type I or basement-membrane extract have been
used successfully in modelling both normal development and cell
transformation (Katz et al., 2005; Katz et al., 2010). Nevertheless,
the analysis of 3D cultures is almost exclusively undertaken using
only 2D techniques, frequently based on analysis of microscopic
sections of formalin-fixed sample sections (Katz et al., 2011; Katz
et al., 2012). This has resulted in lack of knowledge regarding the
3D morphological properties both of human cancer as it occurs
naturally and in 3D culture-based cancer models. Previous work
has partly bridged the gap from 2D to 3D: a metric derived from
2D sections (number of cell clusters) carries with it an implicit
measure of structure in 3D (Franzén et al., 2008). Such clusters
represent fragmentation of the tumour 2D slice and, because the
section is a slice through tissue, this fragmentation might represent
a tumour structure that in 3D has invasive protrusions and/or
tumour budding.
The transition from normal to malignant epithelial tissue involves
many morphological changes, such as cellular depolarisation, loss
of cellular junctions and alterations in rates of proliferation and
apoptosis (Debnath and Brugge, 2005). 3D cultures introduce
environmental cues from the extracellular matrix, enabling more
accurate modelling of tumour behaviour (Egeblad et al., 2010).
Although 3D cultures have been used for study of some cancers
including those of the skin (Amjad et al., 2007), breast (Katz et al.,
2012) and ovaries (Muranen et al., 2012), their analysis is still
performed in single 2D sections.
Here, we have characterised the morphology of cancer spread
in 3D using Minkowski functionals (normalised by volume) in
primary breast tumours grown in type I collagen matrix. Breast
tumours grown in these 3D cultures were analysed, using factorial
analysis by regression, on the basis of four important clinical
biomarkers: histological grade, ER status, HER2 status and node
status. In addition, we analysed tumours treated with tamoxifen,
one of the most common drugs used for patients world-wide.
Although volume-based analysis has shown that ER+ tumours
respond to tamoxifen in agreement with clinical literature (Dowsett
et al., 2005), our more detailed morphometric analysis has led to
several other observations.
ER status is not a discriminator of tumour morphology, neither
in the absence of treatment nor in response to tamoxifen treatment,
once Minkowski functionals are normalised with respect to the
volume of detected tumour objects. This suggests that change in
volume is the correct measurement for tamoxifen response,
regardless of ER status, and our earlier work demonstrates that
change in volume is a major response to tamoxifen treatment.
Lymph node status is only significant in ER– tumours and therefore
of limited application in analysis of tamoxifen response. Because
HER2 is not a significant explanatory variable for any of Minkowski
functionals, HER2 status is not in itself a discriminator of tumour
morphology in the absence of treatment. This observation is
supported in extensive literature, which failed to find any
morphological features unique to HER2+ tumours (Bertos and
Park, 2011).
We make the novel observation that HER2 status is a
discriminator of a differential morphological response to tamoxifen.
Tamoxifen treatment is a significant factor for morphological
response variables IMC/V and SA/V for HER2– tumours but not
for HER2+ tumours. This observation is also supported in other
studies, which showed that HER2 signalling is a mechanism of drug
resistance to endocrine treatment such as tamoxifen (Mullen et al.,
2007). Our study suggests that morphometric variables can quantify
levels of tamoxifen response in sensitive HER2– tumours, and that
these morphometrics will remain unchanged in HER2+ tumours.
Lastly, there was high concordance between the original tumour
grade, as determined by clinical pathologists, and that predicted
by analysis based on Minkowski functionals. Furthermore,
tamoxifen treatment lowered the grade, as expected. Our detailed
analysis showed that this is linked to restoration of acinar and tubule
formation in treated tumours. This novel observation might link
good response to tamoxifen to reformation of normal breast tissue
components, such as cell-cell junctions (Lanigan et al., 2009).
The current study utilised primary tumour material grown in
3D ex vivo. These cultures contain large bodies, each containing
thousands of cells (Leeper et al., 2012). Nonetheless, analysis based
on Minkowski functionals can be readily applied to other 3D studies
Table 3. Change in the explanatory power of the regression model 
for each variable for HER+ and HER– tumours 
Explanatory variables 
Response variables 
IMC/V SA/V ITC/V 
HER2+ tumours 
Tamoxifen 0.69 0.40 0.61 
ER 0.90 0.30 0.54 
Tamoxifen.ER 0.50 0.48 0.77 
HER2– tumours 
Tamoxifen 0.03 <0.01 0.40 
ER 0.40 0.93 0.79 
Tamoxifen.ER 0.45 0.64 0.88 
P-values for the F-test on the change in the explanatory power of the regression model 
for each variable (tamoxifen treatment and ER status) and combination of variables 
introduced with respect to models for response variables (IMC/V, SA/V and ITC/V). 
Results are for HER+ and HER– tumours. Significant effects are highlighted in bold. 
Table 4. Classification table of discriminant factor analysis  
Pathology grading 
Predicted grade Accuracy  
(%) 1 2 3 
Grade 1, all tumours 5 0 0 100 
Grade 2, all tumours 0 4 0 100 
Grade 3, untreated tumours 1 0 12 92.3 
Grade 3, treated tumours 6 0 2 25 
For grade 1 and grade 2 tumours, Minkowski functions predict grade with 100% 
accuracy. For grade 3 untreated and treated tumours, Minkowski functions predict with 
~92% and 25% accuracy, respectively. SA/V, IMC/V and ITC/V were normally distributed 
(Kolmogorov-Smirnoff: P=0.683, P=0.545 and P=0.111, respectively). 
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of epithelial morphology. Previous attempts to define 3D
morphology in the context of cancer relied on smaller scale
structures, containing hundreds of cells at the most. Furthermore,
these classifications are frequently qualitative. For example, Bissell
and co-workers categorised all 3D structures formed by breast
cancer cells into round, mass, grape-like and stellate formations
(Kenny et al., 2007). Subsequent morphological analysis was
insufficient to discriminate between round and mass types and
ultimately settled on three subtypes (Han et al., 2010). Although
this type of analysis is useful for a broad molecular understanding
of 3D structures, it is lacking as a quantitative measure to express
the enormous variability found in human tumours.
The dynamic description offered by using four Minkowski
functionals is a well-developed and powerful analytical approach.
It accurately defines morphological variability in human tumours
by quantitative geometric and topological analysis. This type of
analysis should enable more in-depth association of known
biomarkers with epithelial cancer morphology, as well as better
explaining the response or insensitivity of particular tumours to
treatment. The use of cancer microtissues in high-throughput
screening of drug responses offers a particularly relevant application
(Drewitz et al., 2011; Sundstrom et al., 2012). Such an approach is
usually based on volumetric analysis of 3D spheroids or on area
measurements of 2D projections. Our Minkowski functionals-
based approach can be directly applied in this context to glean
further information regarding drug responses, similarly to the
studies on the effects of tamoxifen described here. A remaining
challenge is to quantitatively analyse the extent of stroma
involvement before and after treatment ex vivo, because this
feature of the tumour is far less uniformly organised than the
epithelia.
METHODS
Tumours, ex vivo culture and OPT data generation
Our data set is based on 3D cultures of primary breast cancer
explants growing ex vivo in the presence of estrogen with or without
tamoxifen (Leeper et al., 2012). The culture system is fully described
(Leeper et al., 2011). Briefly, multiple core biopsies were harvested
from consenting patients at the time of curative surgical resection
for invasive breast cancer. Cores were divided by eye using a scalpel
into 1 mm3 explants. Explants were cultured in a type I collagen
matrix (0.3 mg/ml) for 20 days in the presence of 1.610−10 M -
estradiol (estrogen). At day 8 of culture, half of the growing
explants continued to receive only estrogen, and the other half
received estrogen and 410−6 M tamoxifen for the remaining 12
days (Leeper et al., 2012). The resulting culture materials were
stained with anti-cytokeratin antibody following a standard
protocol, and scanned using an optical projection tomograph
(OPT; Bioptonics 3001M).
For analysis, we had 420 individual 2D image scans for each
tumour. These 2D projections were reconstructed into 3D volume
images using NRecon software. In our data set, we had 30 tumours
comprising five ER+, HER2+ tumours; 12 ER+, HER2– tumours;
three ER–, HER2+ tumours; and ten ER–, HER2– tumours. Five
of the tumours were grade 1, four were grade 2 and 21 were grade
3. Of the 30 tumours, 12 were treated with tamoxifen and 18 were
untreated. Supplementary material Table S1 provides the ER and
HER2 status (±) and tamoxifen treatment (yes or no) for each
tumour. Following reconstruction, volume images were exported
as slices in the BMP file format; this allowed the volume data to
be easily imported into image analysis packages such as FIJI
(ImageJ).
The ER, HER2 and lymph node status and tumour grade were
determined separately by qualified pathologists for 15 breast
cancers as part of the clinical process.
Minkowski functionals
Minkowski functionals are a set of measures that provide a
quantitative description of geometric and topological structure in
n-dimensional space. In 2D Euclidean space, morphology can be
quantified by the three measures: area fraction, boundary length
and the Euler number (Mattfeldt et al., 2007), where the Euler
number describes the connectivity of objects detected within an
image (Legland et al., 2007). In 3D Euclidean space, the Minkowski
functionals are related (by dimensional scaling factors) to volume,
surface area, IMC and ITC, which in turn is related to the Euler
characteristic () by a dimensional scale factor (Arns et al., 2010).
In most cases (such as the work presented here), analysis is carried
out on data having a constant dimensionality (typically either 2D
or 3D) and so a dimensional scaling factor is less important; such
factors are cancelled by taking ratios between the measures. More
generally, the fundamental morphological properties of objects
within D dimensional space are characterised by D+1 Minkowski
functionals (Schmalzing and Buchert, 1997). Because of the general
applicability of the Minkowski functionals to any data set, these
metrics have already been used in a wide range of fields. For
Table 5. Classification table of discriminant factor analysis with 
respect to mitotic count, nuclear pleomorphism and acinar or 
tubule formation 
Pathology grading 
Predicted grade Agreement 
(%) 1 2 3 
Mitotic count 
Untreated grade 1 5* 0 0 100 
Untreated grade 2 1 7* 0 87.5 
Untreated grade 3 1 0 4* 80 
Treated grade 1 4* 0 0 100 
Treated grade 2 1 3* 0 75 
Treated grade 3 0 0 4* 100 
Nuclear pleomorphism 
Untreated grade 2 0 5* 0 100 
Untreated grade 3 0 2 11* 84.6 
Treated grade 2 0 4* 0 100 
Treated grade 3 0 2 6* 75 
Acinar or tubule formation 
Untreated grade 1 3* 0 0 100 
Untreated grade 2 0 3* 0 100 
Untreated grade 3 0 0 12* 100 
Treated grade 1 2* 0 0 100 
Treated grade 2 2 0* 0 0 
Treated grade 3 8 0 0* 0 
*The number of grade predictions made using the Minkowski functionals that agree 
with pathology grades based separately on mitotic count, nuclear pleomorphism and 
acinar or tubule formation. 
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example in 3D data sets, Minkowski functionals analysis of
magnetic resonance images can effectively predict the mechanical
properties of trabecular bone (Boehm et al., 2008). Minkowski
functionals analysis has revealed insights into galaxy clustering
structures and given confidence in other models of galaxy structure
(Hikage et al., 2003). In materials science, Minkowski functionals
have been employed to help understand the dynamics of models
of the microstructure properties of foams (Lautensack and Sych,
2006). In soil science, Minkowski functionals have been used to
characterise soil morphology (Falconer et al., 2012). Likewise, our
data sets concern 3D space and, although volume and surface area
are self-explanatory, IMC and ITC benefit from additional
description here (see also Arns et al., 2010).
In 3D space, any non-spherical curved surface exhibits two
principal curvatures at each point on its surface (whereas a
spherical surface exhibits constant curvature in all directions at all
points on its surface). These principal curvatures are measured
orthogonally and can be referred to as the major and minor
curvatures. The mean curvature, as the name suggests, is found by
taking the arithmetic mean average of these major and minor
curvature measures, and so the IMC is a summation of this
averaged curvature measure over the entire surface. In short, this
provides a summary measure of the overall curvedness of the
surface. Positive IMC values indicate overall convexity; negative
IMC values indicate overall concavity. ITC is a purely topological
measure describing connectedness according to some local
neighbourhood of the image elements. In the 3D case (as in the
work presented here) the six-connected (Von-Neumann)
neighbourhood is used. In the case of digital images, ITC is – in
simple terms – estimated as the sum of the number of regions or
clusters of connected image elements (2D pixels or 3D voxels)
comprising the objects of interest added to the number of
completely enclosed background regions minus the number of
tunnels, i.e. background regions piercing connected object regions.
Consequently, a large ITC value represents a largely disjointed
pattern. By combining volume, surface area, IMC and ITC, the
fundamental measures of both geometry and topology are
represented by Minkowski functionals. We use established
estimation algorithms (Ohser and Mücklich, 2000) and implement
them (Falconer et al., 2012) to characterise 3D morphology of
porous media and the simulated distribution of both water and
fungal biomass within the pore space.
Image processing and analysis
For image processing, we used FIJI (http://fiji.sc/), an open source
distribution, with a range of additional software libraries, of the
ImageJ image processing software suite (ImageJA 1.45b, open
source software, National Institutes of Health, Bethesda, MD). FIJI
was used to process the 2D slice images obtained from the volume
reconstruction of OPT scans. The images were filtered and then
segmented to produce clear boundaries of the embedded tumours.
Specifically, image stacks were imported into FIJI and the images
despeckled and outliers removed using the standard operators
provided by FIJI. Subsequently, the widely used Otsu method for
thresholding (also available as standard in FIJI) was applied.
Following thresholding, images were despeckled once again. These
segmented and thresholded 3D tomography images were analysed
using the estimators described by Ohser and Mücklich (Ohser and
Mücklich, 2000) and implemented by Falconer et al. (Falconer et
al., 2012) to obtain estimates for each tumour of the four Minkowski
functional measures, i.e. the volume fraction, surface area, IMC
and ITC.
Statistical analysis
The factorial analysis of variance by regression was undertaken
using Genstat 10.1 statistical analysis software. The t-tests together
with discriminant functional analysis and normality tests were
carried out using Microsoft Excel supplemented with XLStat
(www.xlstat.com).
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